Novogen Terminates Preclinical Program, Will Cut an Undisclosed Number of Jobs

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks3.jpg" NAME"Novogen Terminates Preclinical Program, Will Cut an Undisclosed Number of Jobs" ALT"Novogen Terminates Preclinical Program, Will Cut an Undisclosed Number of Jobs"April 6, 2017By Mark Terry, BioSpace.com... Source:…

Continue ReadingNovogen Terminates Preclinical Program, Will Cut an Undisclosed Number of Jobs

Look Out Biotech! Google's Parent Sets Sights on Poaching Top Talent From Life Sciences and Healthcare

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-google.jpg" NAME"Look Out Biotech! Google's Parent Alphabet Sets Sights on Poaching Top Talent From Life Sciences and Healthcare" ALT"Look Out Biotech! Google's Parent Alphabet Sets Sights on Poaching Top…

Continue ReadingLook Out Biotech! Google's Parent Sets Sights on Poaching Top Talent From Life Sciences and Healthcare

Valeant Plummets After Revealing Jaw-Dropping Payday for Its CEO

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-valeant-joseph-papa.jpg" NAME"Valeant Plummets After Revealing Jaw-Dropping Payday For Its CEO" ALT"Valeant Plummets After Revealing Jaw-Dropping Payday For Its CEO"April 5, 2017By Alex Keown, BioSpace.com Breaking News Staff... Source: BioSpace

Continue ReadingValeant Plummets After Revealing Jaw-Dropping Payday for Its CEO

Data To Be Presented At Highlighting GENFIT???s Latest Progress In NASH Biomarker Diagnostics, Identifying Novel Compounds With Potent Antifibrotic Properties, And Illustrating The Opportunities In Anti-NASH Drug Combinations

  • Post author:
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingData To Be Presented At Highlighting GENFIT???s Latest Progress In NASH Biomarker Diagnostics, Identifying Novel Compounds With Potent Antifibrotic Properties, And Illustrating The Opportunities In Anti-NASH Drug Combinations